Japanese pharmaceutical firm Shionogi & Co said Monday it is looking to apply for approval of its oral COVID-19 drug as early as next week after mid-phase clinical…
Japanese pharmaceutical firm Shionogi & Co said Monday it is looking to apply for approval of its oral COVID-19 drug as early as next week after mid-phase clinical…